Neo Ivy Capital Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$18K Buy
+482
New +$18.6K 0.04% 232
2022
Q4
$911K Buy
+15,120
New +$885K 0.62% 33

Other funds holding PRTA

Neo Ivy Capital Management's PRTA Position: Q4 2023 in Review

Neo Ivy Capital Management opened a new position in Prothena Corp (PRTA) in Q4 2023: 482 shares worth $18K. The stake represents 0.04% of the portfolio and ranks #232 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in PRTA as recently as Q4 2022.

Neo Ivy Capital Management first reported a position in PRTA in Q4 2022 and has held it in 2 quarters since. The position peaked at $911K in Q4 2022. 187 funds tracked by Wall St. Rank hold PRTA as of Q4 2023.

  • Neo Ivy Capital Management held 482 shares of Prothena Corp worth $18K as of Q4 2023.
  • Prothena Corp was a new Neo Ivy Capital Management position in Q4 2023.
  • Prothena Corp made up 0.04% of Neo Ivy Capital Management's portfolio in Q4 2023, its #232 holding.
  • Neo Ivy Capital Management first reported a position in Prothena Corp in Q4 2022 and has held it in 2 quarters since.
  • Neo Ivy Capital Management's Prothena Corp position peaked at $911K in Q4 2022.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2023.

Based on Neo Ivy Capital Management's 13F filing for Q4 2023, filed 26 Feb 2024.